ConductScience.org, home

Trial · NCT04385667

LVN- IUS Versus Oral Megesterol Acetate in Treatment of Atypical Endometrial Hyperplasia

NCT04385667, Phase 2, Phase 3, Completed, Zagazig University

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. LVN- IUS Versus Oral Megesterol Acetate in Treatment of Atypical Endometrial Hyperplasia. Trials, record NCT04385667. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04385667

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
LVN- IUS Versus Oral Megesterol Acetate in Treatment of Atypical Endometrial Hyperplasia
NCT number
NCT04385667
Status
Completed
Phases
Phase 2, Phase 3
Enrollment
143 participants, actual
Lead sponsor
Zagazig University
Conditions
Atypical Endometrial Hyperplasia
Interventions
levonorgestrel intrauterine system (LNG-IUD), Oral Megesterol 160 mg daily
First posted
2020-05-13
Last updated
2023-01-03

Source ClinicalTrials.gov

Registered outcomes6

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryThe success rate to accomplish complete regression of atypical endometrial hyperplasia15 monthThe success rate to accomplish complete regression of atypical endometrial hyperplasia
Secondarya- Duration needed to accomplish the complete recovery15 monthstime till regression
Secondaryb- The partial regression and failure rates.8 monthsincidence of partial regression and therapy failure
Secondaryc- Differential response rates between premenopausal and postmenopausal cases.15 monthsresponse rate in both premenopause and postmenopause women
Secondaryd- The risk of thromboembolic complications15 monthsincidence of thromboembolism with therapy
Secondaryf- Metabolic complications rates15 monthsoccurence of diabetes or hypertension ...ets

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers5

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
20613899BACKGROUNDPubMed
20934679BACKGROUNDPubMed
22863972BACKGROUNDPubMed
26428941BACKGROUNDPubMed
38425141DERIVEDPubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT04385667

GET https://conductscience.org/api/trials/v1/NCT04385667/registered